2026

1. Arslan, D. F., Civan, C., Sanli, M. O., Has Simsek, D., Ekenel, M., Basaran, M., Erdem, S., Ozcan, F., Kuyumcu, S., & Sanli, Y. (2026). Outcomes of [(177)Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide in metastatic castration-resistant prostate cancer: a single-center retrospective study. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-026-08149-x
2. Al-Ramadhani, A. Q. M., Şenışık, A. M., Kovan, B., Mutlu, E., Demir, B., & Kuyumcu, S. (2026). Clinical evaluation of Chang attenuation-correction parameterization for CT-free (177)Lu SPECT organ quantification: implications for safety dosimetry. Appl Radiat Isot, 237, 112854. https://doi.org/10.1016/j.apradiso.2026.112854
3. Arslan, D. F., Ozkan, Z. G., Bayram, A., Zorba, D. D., Isık, E. G., Sanli, Y., Simsek, D. H., Erturk, S. M., & Kuyumcu, S. (2026). Diagnostic performance of (18)F-FDG PET/CT radiomics-based machine learning models for pancreatic lesion characterisation: comparison with visual assessment and evaluation of human-radiomics synergy. Eur J Nucl Med Mol Imaging, 53(12), 7288-7298. https://doi.org/10.1007/s00259-026-08102-y
4. Denizmen Zorba, D., Kuyumcu, S., Has Simsek, D., Isik, E. G., Poyanli, A., Kubat Uzum, A., Buyukkaya, F., Onder, S., Aksakal, N., Iscan, Y., Ozkan, Z. G., & Sanli, Y. (2026). A novel imaging approach in hyperparathyroidism: [(68)Ga]Ga-Trivehexin PET/CT. Eur J Nucl Med Mol Imaging, 53(11), 6651-6660. https://doi.org/10.1007/s00259-026-07965-5
5. Denizmen Zorba, D., Has Simsek, D., Arslan, D. F., Isik, E. G., Ozkan, Z. G., Sanli, Y., Hacisahinogullari, H., Iscan, Y., & Kuyumcu, S. (2026). Diagnostic value of (68)Ga-DOTATATE PET/CT volumetric parameters in differentiating adrenal lesions. Ann Nucl Med, 40(6), 723-730. https://doi.org/10.1007/s12149-026-02175-3
6. Isik, E. G., Topal, E., Barburoglu, M., Kuyumcu, S., & Sanli, Y. (2026). (68)Ga-DOTA-TATE PET/CT in the assessment of cranial and spinal hypertrophic pachymeningitis. Clin Nucl Med, 51(5), 444-445. https://doi.org/10.1097/RLU.0000000000006347
7. Denizmen Zorba, D., Has Simsek, D., Sanli, Y., Karacam, M. I., Ergin, O. N., Cagatay, A. A., Buyukkaya, F., & Kuyumcu, S. (2026). Evaluating chronic bone and soft tissue infections with [(68)Ga]Ga-Pentixafor PET/CT: a head-to-head comparison with scintigraphy. Eur J Nucl Med Mol Imaging, 53(5), 3271-3282. https://doi.org/10.1007/s00259-025-07749-3
8. Denizmen Zorba, D., Arslan, D. F., Sanli, Y., & Kuyumcu, S. (2026). Optimizing intrahepatic cholangiocarcinoma staging: comparison of [(18)F]FDG, [(68)Ga]Ga-FAPI, and [(68)Ga]Ga-Trivehexin PET/CT imaging. Clin Nucl Med, 51(8), e657-e658. https://doi.org/10.1097/RLU.0000000000006310
9. Karaoğlan, H., Can, C., Akdeniz, N., Şimşek, D. H., Güzel, Y., Soylu, B., Kepenek, F., Kaplan, İ., Kuyumcu, S., Güzel, F., Zorba, D. D., İpek, F. K., & Kömek, H. (2026). Comparison of the diagnostic accuracy of [(68)Ga]Ga-Trivehexin PET/computed tomography and [(18)F]FDG PET/computed tomography in nodal staging of various solid tumors. Nucl Med Commun, 47(4), 470-478. https://doi.org/10.1097/MNM.0000000000002109

2025

10. Oflas, M., Simsek, D. H., Yilmaz, R., Cabioglu, N., Onder, S., Isik, E. G., Ozkan, Z. G., Aydiner, A., Sanli, Y., & Kuyumcu, S. (2025). The Schrödinger’s cat paradox: can MAMMI PET with (68)Ga-FAPI determine pathological complete response to neoadjuvant chemotherapy in breast cancer omitting surgery? Cancer Biother Radiopharm, 41(5), 410-419. https://doi.org/10.1177/10849785251404410
11. Kucuk, N. O., Coskun, N., Araz, M., Alan Selcuk, N., Berberoglu, K., Ozdemir, E. C., Gumuser, F. G., Kuyumcu, S., Sezgin, C., Sanli, O., Sanli, Y., Sendur, M. A. N., & Urun, Y. (2025). Initial multicenter experience with [(161)Tb]Tb-PSMA in [(177)Lu]Lu-PSMA-refractory metastatic castration-resistant prostate cancer: preliminary results. J Nucl Med, 66(12), 1921-1926. https://doi.org/10.2967/jnumed.125.270952
12. Mutlu, E., Şenişik, A. M., Kovan, B., Kuyumcu, S., & Demir, B. (2025). Threshold optimization for lesion size in lutetium-177 single-photon emission computed tomography imaging: a phantom-based evaluation. Nucl Med Commun, 47(2), 160-167. https://doi.org/10.1097/MNM.0000000000002084
13. Denizmen Zorba, D., Isik, E. G., Arslan, D. F., Sen, C., & Kuyumcu, S. (2025). Enhancing nasopharyngeal cancer follow-up: (68)Ga-Trivehexin PET/CT for distinguishing recurrence from infection. Clin Nucl Med, 51(3), e201-e202. https://doi.org/10.1097/RLU.0000000000006015
14. Denizmen Zorba, D., Kuyumcu, S., Kubat Uzum, A., Isik, E. G., & Sanli, Y. (2025). Detection of recurrent parathyroid cancer using (68)Ga-Trivehexin PET/CT. Clin Nucl Med, 50(7), e451-e452. https://doi.org/10.1097/RLU.0000000000005735
15. Deniz, G., Denizmen Zorba, D., Ozkan, Z. G., Kuyumcu, S., & Sanli, Y. (2025). Invasive lobular carcinoma of the breast with solid renal metastasis on (18)F-FDG PET/CT. Clin Nucl Med, 50(11), e671-e672. https://doi.org/10.1097/RLU.0000000000005870
16. Kuyumcu, S., Denizmen Zorba, D., & Özkan, Z. G. (2025). (68)Ga-Trivehexin PET/CT uptake in malignant and fibrotic lung tissue: refining diagnostic applications. Eur J Nucl Med Mol Imaging, 52(10), 3513-3514. https://doi.org/10.1007/s00259-025-07193-3
17. Topal, E., Kovan, B., İribas, A., Kuyumcu, S., Basaran, M., Malçok Demirtaş, A., Sanli, O., & Sanli, Y. (2025). Impact of extended [(177)Lu]Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued? Eur J Nucl Med Mol Imaging, 52(9), 3135-3144. https://doi.org/10.1007/s00259-025-07125-1
18. Kuyumcu, S., & Şanlı, Y. (2025). Reflections on Terbium-149: advancing preclinical research in targeted alpha therapy. Eur J Nucl Med Mol Imaging, 52(8), 2759-2760. https://doi.org/10.1007/s00259-025-07151-z
19. Oflas, M., Has Şimşek, D., Kuyumcu, S., Yılmaz Kıran, M., & Şanlı, Y. (2025). The utility of (18)F-FDG PET/CT in detecting multiple metastases in papillary renal cell carcinoma. Mol Imaging Radionucl Ther, 34(1), 64-65. https://doi.org/10.4274/mirt.galenos.2024.02259
20. Isik, E. G., Has Simsek, D., Gul, N., Erturk, S. M., Buyukkaya, F., Soyluk Selcukbiricik, O., Iscan, A. Y., Özkan, Z. G., Sanli, Y., Mudun, A., & Kuyumcu, S. (2025). Head-to-head comparison of (68)Ga-FAPI-04 and (68)Ga-DOTA-TATE PET/CT in recurrent medullary thyroid cancer. Clin Nucl Med, 50(2), e80-e86. https://doi.org/10.1097/RLU.0000000000005558

2024

21. Kuyumcu, S., Denizmen, D., Has-Simsek, D., Poyanli, A., Uzum, A. K., Buyukkaya, F., Isik, E. G., Onder, S., Aksakal, N., Ozkan, Z. G., & Sanli, Y. (2024). (68)Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism. Eur J Nucl Med Mol Imaging, 51(13), 3912-3923. https://doi.org/10.1007/s00259-024-06846-z
22. Kuyumcu, S., & Has-Şimşek, D. (2024). Evaluating the efficacy of [(177)Lu]Lu-FAP-2286 in combination therapy for metastatic breast cancer. Eur J Nucl Med Mol Imaging, 51(13), 4188-4189. https://doi.org/10.1007/s00259-024-06864-x
23. Kuyumcu, S., Isik, E. G., Şen, C., Has-Şimsek, D., Başaran, B., Özkan, Z. G., Büyükkaya, F., & Şanlı, Y. (2024). [(68)Ga]Ga-FAPI04 Outperforms [(18)F]FDG PET/CT for Detecting Nodal Metastasis of Head and Neck Squamous Cell Carcinoma: A Single-Center Experience. Cancer Biother Radiopharm. https://doi.org/10.1089/cbr.2024.0112
24. Civan, C., Has Şimşek, D., Vurallı Bakkaloğlu, D., & Kuyumcu, S. (2024). (18)F-FDG and (68)Ga-FAPI-04 PET/CT Findings of a Rare Epithelial-myoepithelial Carcinoma Arising From Ex Pleomorphic Adenoma of Parotid. Mol Imaging Radionucl Ther, 33(2), 125-128. https://doi.org/10.4274/mirt.galenos.2023.83435
25. Civan, C., Işık, E. G., Has Şimşek, D., Altınkaynak, M., & Kuyumcu, S. (2024). Diagnosis and Evaluation of Treatment Response in Relapsing Polychondritis Using (18)F-FDG PET/CT. Mol Imaging Radionucl Ther, 33(2), 109-111. https://doi.org/10.4274/mirt.galenos.2023.80958
26. Civan C, Ozkan ZG, Ozkan B, Isik EG, Erdogdu E, Has Simsek D, Duman S, Sanli Y, Kara M, Kuyumcu S, Toker A. The Role of [18F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage. Cancer Biother Radiopharm. 2024
27. Has Simsek D, Oflas M, Yilmaz R, Tukenmez M, Kuyumcu S. Combination of 68Ga- FAPI-04 and Dedicated Breast PET (MAMMI PET) Outperformed Breast MRI and 18F-FDG PET/CT by Revealing Nipple and Skin Involvement of Breast Cancer. Clin Nucl Med. 2024
28. Kovan B, Denizmen D, Civan C, Kuyumcu S, Isik EG, Has Simsek D, Ozkan ZG, Poyanli A, Demir B, Sanli Y. Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90Y Selective Internal Radiation Therapy Planning. Cancer Biother Radiopharm. 2024 Jan 24

2023

29. Civan C, Kuyumcu S, Has Simsek D, Sanli O, Isik EG, Ozkan ZG, Hurdogan O, Sanli Y. The role of [(68) Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study. Eur J Nucl Med Mol Imaging 2023 doi: 10.1007/s00259-023-06461-4.
30. Has Simsek D, Guzel Y, Denizmen D, Sanli Y, Buyukkaya F, Kovan B, Komek H, Isik EG, Ozkan ZG, Kuyumcu S. The inferior performance of [(68)Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [(177)Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors. Eur J Nucl Med Mol Imaging 2023 doi: 10.1007/s00259-023-06497-6.
31. Kovan B, Demir B, Işık EG, Has Şimşek D, Özkan ZG, Kuyumcu S, Türkmen C, Şanlı Y. An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatment dosimetry. Radiat Prot Dosimetry 2023;199:1274-1283.
32. Topal E, Has Simsek D, Vatansever S, Sanli Y, Kuyumcu S. Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer: Excellent Response to 177Lu-PSMA With No Adrenal Insufficiency. Clin Nucl Med 2023 doi: 10.1097/rlu.0000000000004964.
33. Civan C, Isik EG, Karadogan S, Sanli Y, Kuyumcu S. 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer.  Clin Nucl Med. 2023 May 1;48(5):e223-e224.
34. Denizmen D, Isik EG, Buyukkaya F, Kuyumcu S. 68 Ga-FAPI04 Versus 68 Ga-DOTATATE PET/CT in a Patient With Multiple Meningioma. Clin Nucl Med. 2023 May 1;48(5):e244-e245.
35. Civan C, Isik EG, Has Simsek D, Buyukkaya F, Kuyumcu S. Utility of 68 Ga-FAPI-04 PET/CT in Adenoid Cystic Carcinoma Compared With 18 F-FDG PET/CT : Two Case Reports. Clin Nucl Med. 2023 Jul 1;48(7):e350-e352.
36. Civan C, Has Simsek D, Isik EG, Sanli Y, Kuyumcu S. FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT. Clin Nucl Med. 2023 May 23.
37. Kiran MY, Has Simsek D, Sanli Y, Kuyumcu S. 18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer. Clin Nucl Med. 2023 Feb 1;48(2):e87-e88. doi: 10.1097/RLU.0000000000004532.
38. Civan C, Isik EG, Karadogan S, Sanli Y, Kuyumcu S. 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer. Clin Nucl Med. 2023 May 1;48(5):e223-e224. doi: 10.1097/RLU.0000000000004587.
39. Denizmen D, Isik EG, Buyukkaya F, Kuyumcu S. 68 Ga-FAPI04 Versus 68 Ga- DOTATATE PET/CT in a Patient With Multiple Meningioma. Clin Nucl Med. 2023 May 1;48(5):e244-e245. doi: 10.1097/RLU.0000000000004617.
40. Civan C, Isik EG, Has Simsek D, Buyukkaya F, Kuyumcu S. Utility of 68Ga- FAPI-04 PET/CT in Adenoid Cystic Carcinoma Compared With 18F-FDG PET/CT: Two Case Reports. Clin Nucl Med. 2023 May 11. doi: 10.1097/RLU.0000000000004687.

2022

41. Has Simsek D, Emiroglu S, Yilmaz R, Bayram A, Isik EG, Tukenmez M, Kuyumcu S,et al. PECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer. Clin Nucl Med. 2022 Nov 1;47(11):e682-e688. doi: 10.1097/RLU.0000000000004340.
42. Has Simsek D, Kuyumcu S, Karadogan S, Ozkan ZG, Isik EG, Basaran M, Sanli MO, Sanli Y. Outcome of 177Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters: A Single-Center Experience. Clin Nucl Med. 2022 May 11. doi: 10.1097/RLU.0000000000004222.
43. Civan C, Has Simsek D, Kiran MY, Isik EG, Ozkan ZG, Sanli Y, Kuyumcu S. Comparison of 2D planar and 3D volumetric methods for estimation of split renal function by 99mTc-DMSA scintigraphy.  Phys Med. 2022 Feb 5;95:83-88. doi: 10.1016/j.ejmp.2022.01.010
44. Civan C, Apaydin Arikan E, Has Simsek D, Sanli O, Kuyumcu S. Bilateral Testicular Mass Presenting as a Rare Manifestation of Extramedullary Plasmacytoma on 18F-FDG PET/CT. Clin Nucl Med. 2022 Jan 12. doi: 10.1097/RLU.0000000000004043

2021

45. Kuyumcu S, Sanli Y, Subramaniam RM. Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management. Front Oncol. 2021 Nov 11;11:758958. doi: 10.3389/fonc.2021.758958.
46. Özkan ZG, Has Şimşek D, Kuyumcu S, Oflas M, Işık EG, Doğan İ, Karabulut S, Şanlı Y. Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA. Ann Nucl Med. 2021 Oct 14. doi: 10.1007/s12149-021-01684-7
47. Sanli Y, Kuyumcu S, Simsek DH, Büyükkaya F, Civan C, Isik EG, Ozkan ZG, Basaran M, Sanli O. ²²⁵Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate cancer: A Single-Center Experience. Clin Nucl Med. 2021 Sep 27. doi: 10.1097/RLU.0000000000003925
48. Kuyumcu S, Kıran MY, Apaydın Arıkan E, Yeğen G, Şanlı Y. [⁶⁸Ga]-Pentixafor PET/CT imaging of lymphoproliferative malignancies. Clinical and Translational Imaging (2021). doi: 10.1007/s40336-021-00458-5
49. Isik EG, Has-Simsek D, Sanli O, Sanli Y, Kuyumcu S. Fibroblast Activation Protein-Targeted PET Imaging of Metastatic Castration-Resistant Prostate Cancer Compared With ⁶⁸Ga-PSMA and ¹⁸F-FDG PET/CT. Clin Nucl Med. 2021 Aug 5. doi: 10.1097/RLU.0000000000003837.
50. Isik EG, Kuyumcu S, Ozkan ZG, Has Simsek D, Sanli Y. Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on ¹⁸F-FDG, ⁶⁸Ga-DOTATATE, and ⁶⁸Ga-FAPI04 PET/CT. Clin Nucl Med. 2021 Aug 5. doi: 10.1097/RLU.0000000000003843.
51. Kiran MY, Apaydin Arikan E, Sanli Y, Yegen G, Kuyumcu S. CXCR4 Expression Demonstrated by 68Ga-Pentixafor PET/CT Imaging in a Case of Systemic Mastocytosis Mimicking Lymphoma. Clin Nucl Med. 2021 Jul 14. doi:10.1097/RLU.0000000000003817
52. Oflas M, Ozluk Y, Sanli O, Ozkan ZG, Kuyumcu S. 68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes. Clin Nucl Med. 2021 Jul 20. doi: 10.1097/RLU.0000000000003814.
53. Kuyumcu S, Isik EG, Tiryaki TO, Has-Simsek D, Sanli Y, Buyukkaya F, Özkan ZG, Kalayoglu-Besisik S, Unal SN. Prognostic significance of ⁶⁸Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results. Ann Nucl Med. 2021 Jun 29. doi: 10.1007/s12149-021-01652-1. PMID: 34185263
54. Kuyumcu S, Işık EG, Sanli Y. Liver metastases from medullary thyroid carcinoma detected on 68Ga-FAPI-04 PET/CT. Endocrine. 2021 Jun 24. doi: 10.1007/s12020-021-02800-3.
55. Has Simsek D, Kuyumcu S, Ozkan ZG, et al. Demonstration of in vivo estrogen receptor status with 16α- [(18)F]fluoro-17ß-oestradiol (FES) PET/CT in a rare case of benign metastasizing leiomyoma.  Eur J Nucl Med Mol Imaging. 2021.
56. Kuyumcu S, Kovan B, Sanli Y, et al. Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04. Clin Nucl Med. 2021 Aug 1;46(8):641-646.
57. Has Simsek D, Kuyumcu S, Karadogan S, et al. Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer? . Ann Nucl Med. 2021;35:680-690.
58. Has Simsek D, Civan C, Ekenel M, Kuyumcu S, Sanli Y. 177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor.  Clin Nucl Med. 2021;46:415-418.
59. Has Simsek D, Isik EG, Engin MN, Kuyumcu S, Mudun A, Sanli Y. Somatostatin receptor-positive breast lesions on ⁶⁸Ga-DOTATATE PET/CT. Ann Nucl Med. 2021 Feb;35(2):270-277.

2020 ve öncesi

60. Simsek, D. H., Sanli, Y., Civan, C., Engin, M. N., Isik, E. G., Ozkan, Z. G., & Kuyumcu, S. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer? Ann Nucl Med, 34(7), 476-485.
61. Kuyumcu S, Has-Simsek D, Iliaz R, Sanli Y, Buyukkaya F, Akyuz F, Turkmen C. Evidence of Prostate-Specific Membrane Antigen Expression in Hepatocellular Carcinoma Using 68Ga-PSMA PET/CT. Clin Nucl Med. 2019 ;44(9):702-706.
62. Has Simsek D, Kuyumcu S, Agaoglu FY, Unal SN. Radionuclide Therapy With 177Lu-PSMA in a Case of Metastatic Adenoid Cystic Carcinoma of the Parotid. Clin Nucl Med. 2019;44(9):764-766.
63. Simsek DH, Sanli Y, Kuyumcu S, Engin MN, Buyukkaya F, Demirci E. Clinical Impact of Lower-Limb Imaging in (68)Ga-PSMA PET/CT for Patients with Prostate Cancer. J Nucl Med Technol. 2019;47(3):233-237.
64. Sanli Y, Garg I, Kandathil A, Kendi T, Zanetti MJB, Kuyumcu S, et al. Neuroendocrine Tumor Diagnosis and Management: Ga-68-DOTATATE PET/CT. American Journal of Roentgenology. 2018;211(2):267-77.
65. Kuyumcu S, Yilmaz E, Buyukkaya F, Ozkan ZG, Unal SN. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT. Clinical Nuclear Medicine. 2018;43(8):606-8.
66. Simsek DH, Sanli Y, Kuyumcu S, Basaran B, Mudun A. Ga-68-DOTATATE PET-CT imaging in carotid body paragangliomas. Annals of Nuclear Medicine. 2018;32(4):297-301.
67. Simsek, D. H., Kuyumcu, S., Sanli, Y., Ozkan, Z. G., Ozkan, B., Turkmen, C., Yilmazbayhan, E. D., Mudun, A. The Role of 18f-Fdg Pet-Ct in Diagnosis and Prediction of Prognosis in Malignant Pleural Mesothelioma. Journal of Istanbul Faculty of Medicine-Istanbul Tip Fakultesi Dergisi, 82(4), 168-173.
68. Has Simsek D, Sanli Y, Kuyumcu S, Yilmaz E, Ozkan ZG, Turkmen C, et al. Post-Therapy Imaging After Radioactive Iodine Therapy For Differentiated Thyroid Cancer: The Contribution of SPECT-CT Imaging To Planar Imaging. Journal of Istanbul Faculty of Medicine-Istanbul Tip Fakultesi Dergisi. 2018;81(4):106-14.
69. Isik EG, Kuyumcu S, Kebudi R, Sanli Y, Karakas Z, Cakir FB, et al. Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of (18)FDG-PET/CT according to Delta SUVmax, Deauville 5-point scale and IHP criteria. Annals of Nuclear Medicine. 2017;31(9):660-8.
70. Sanli Y, Kuyumcu S, Sanli O, Buyukkaya F, Iribas A, Alcin G, et al. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer. Annals of Nuclear Medicine. 2017;31(9):709-17.
71. Ozkan ZG, Unal SN, Kuyumcu S, Sanli Y, Gecer MF, Ozcinar B, et al. Clinical Utility of Tc-99m MIBI SPECT/CT for Preoperative Localization of Parathyroid Lesions. Indian Journal of Surgery. 2017;79(4):312-8.
72. Has Simsek D, Sanli Y, Kuelle CB, Karanlik H, Kilic B, Kuyumcu S, et al. Correlation of F-18-FDG PET/CT with pathological features and survival in primary breast cancer. Nuclear Medicine Communications. 2017;38(8):694-700.
73. Vatankulu B, Isik G, Kocael P, Kuyumcu S, Ilvan S, Sager S, et al. Do F-18-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men? Nuclear Medicine Communications. 2016;37(12):1273-81.
74. Simsek DH, Kuyumcu S, Bilgic B, Isik EG, Turkmen C, Adalet I. An Incidental Solitary Plasmacytoma of Bone Mimicking Neuroendocrine Tumor Metastasis on Ga-68-DOTATATE Positron Emission Tomography/Computed Tomography. Molecular Imaging and Radionuclide Therapy. 2016;25(3):147-9.
75. Vatankulu B, Sanli Y, Saglam EK, Kuyumcu S, Ozkan ZG, Yilmaz E, et al. Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer? Molecular Imaging and Radionuclide Therapy. 2015;24(3):120-7.
76. Ozkan ZG, Poyanli A, Ucar A, Kuyumcu S, Akyuz F, Keskin S, et al. Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis. Cancer Biotherapy and Radiopharmaceuticals. 2015;30(3):132-8.
77. Ozkan ZG, Kuyumcu S, Uzum AK, Gecer MF, Ozel S, Aral F, et al. Comparison of Ga-68-DOTATATE PET-CT, F-18-FDG PET-CT and Tc-99m-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma. Nuclear Medicine Communications. 2015;36(3):242-50.
78. Kuyumcu S, Sanli Y, Yegen G, Mudun A. Candida esophagitis mimicking esophageal malignancy on 18FDG PET/CT. Turkish Journal of Gastroenterology. 2015;26(1):63-4.
79. Kuyumcu S, Adalet I, Isik EG, Unal SN. Impact of Nonosseous Findings on (18)F-NaF PET/CT in a Patient with Ductal Breast Carcinoma. Nucl Med Mol Imaging. 2014 Mar;48(1):72-4.
80. Simsek DH, Kuyumcu S, Turkmen C, Sanli Y, Aykan F, Unal S, et al. Can Complementary Ga-68-DOTATATE and F-18-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors? Journal of Nuclear Medicine. 2014;55(11):1811-7.
81. Turkmen C, Kilicoglu O, Dikici F, Bezgal F, Kuyumcu S, Gorgun O, et al. Survival analysis of Y-90 radiosynovectomy in the treatment of haemophilic synovitis of the knee: a 10-year retrospective review. Haemophilia. 2014;20(1):E45-E50.
82. Kuyumcu S, Turkmen C, Ozluk Y, Kilicaslan I, Unal S. Microscopic polyangiitis on F-18-FDG PET/CT of a patient with fever of unknown origin presenting as isolated diffuse renal hypermetabolism. European Journal of Nuclear Medicine and Molecular Imaging. 2013;40(8):1295-6.
83. Kuyumcu S, Ozkan ZG, Sanli Y, Yilmaz E, Mudun A, Adalet I, et al. Physiological and tumoral uptake of Ga-68-DOTATATE: standardized uptake values and challenges in interpretation. Annals of Nuclear Medicine. 2013;27(6):538-45.
84. Kuyumcu S, Adalet I, Sanli Y, Turkmen C, Ozkan ZG, Yilmazbayhan D. Somatostatin receptor scintigraphy with In-111-octreotide in pulmonary carcinoid tumours correlated with pathological and (18)FDG PET/CT findings. Annals of Nuclear Medicine. 2012;26(9):689-97.
85. Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, et al. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels. Annals of Nuclear Medicine. 2012;26(7):551-8.
86. Sanli Y, Bakir B, Kuyumcu S, Ozkan ZG, Gulluoglu M, Bilge O, et al. Hepatic Adenomatosis May Mimic Metastatic Lesions of Liver With F-18-FDG PET/CT. Clinical Nuclear Medicine. 2012;37(7):697-8.
87. Sanli Y, Ozkan ZG, Kuyumcu S, Yanar H, Balik E, Tokmak H, et al. Role of red blood cell scintigraphy for determining the localization of gastrointestinal bleeding. Ulusal Travma Ve Acil Cerrahi Dergisi-Turkish Journal of Trauma & Emergency Surgery. 2012;18(3):225-30.
88. Sanli Y, Kuyumcu S, Ozkan ZG, Isik G, Karanlik H, Guzelbey B, et al. Increased FDG uptake in breast cancer is associated with prognostic factors. Annals of Nuclear Medicine. 2012;26(4):345-50.
89. Tamam M, Adalet I, Bakir B, Tuerkmen C, Darendeliler F, Bas F, Kuyumcu S Diagnostic spectrum of congenital hypothyroidism in Turkish children. Pediatrics International. 2009;51(4):464-8.
90. ZG Özkan, Y Sanli, Kuyumcu S, E Yilmaz, I Adalet, SN Unal (2012). Iyi diferansiye tiroid kanseri hastalarında rekürrens veya metastaz süphesinde F18-FDG PET-BT’nin yeri. Endokrinolojide diyalog, 9(2), 57-63.
91. Y Sanli, I Adalet, C Türkmen, H Yanar, Y Kapran, Kuyumcu S, S Cantez (2004). Detection of GIS bleeding by red blood cell scintigraphy in a gastrointestinal stromal tumor. Turkish journal of nuclear medicine
92. EG Isik, E Yılmaz, Kuyumcu S, D Has, MF Geçer, SN Ünal, I Adalet (2013). Kemik sintigrafisi bulgularının yönlendirdigi ektopik (mediastinal) paratiroid adenomu. Endokrinolojide Diyalog

1. Y Sanli, C Turkmen, Kuyumcu S, S Ozturk, S Aday, A Turkmen, M Sever, A Mudun, S Cantez The role of single injection plasma clearance technique with Tc-99m DTPA for the measurement of GFR in living donor candidates for renal transplantation.. Annual Congress of the European Association of Nuclear Medicine, Helsinki, Finland, September 4-8; 2004
2. A Mudun, K Berbero lu, V Özmen, M Muslumanoglu, A Igci, E Yavuz, S Tuzlal , H Tokmak, MO Tamam, Kuyumcu S, C Turkmen, S Cantez The value of combined peritumoral and subdermal injection techniques for lymphoscintigraphy in detection of sentinel lymph node in breast carcinoma. Annual Congress of the European Association of Nuclear Medicine, Helsinki, Finland, September 4-8; 2004
3. Kuyumcu S, Y Sanli, ZG Ozkan, C Turkmen, A Toker, A Mudun The role of 18F-FDG PET/CT in identification of thymic epithelial tumours correlated with histopathological data:An emphasis on local recurrence.. 1. Balkan Congress of Nuclear Medicine, Antalya, Turkey 2012
4. Kuyumcu S, Y Sanli, ZG Ozkan, B Ozkan, C Turkmen, D Yilmazbayhan, A Toker, I Adalet The value of 18F-FDG PET/CT in the diagnosis of pulmonary carcinoid tumours: Correlation with Ki67 indexes. 1. Balkan Congress of Nuclear Medicine, Antalya, Turkey 2012
5. B Vatankulu, Y Sanli, E Kaytan Saglam, Kuyumcu S, E Y lmaz, G Ozkan, S Purisa, I Adalet The role of FDG PET/CT findings in predicting survival in patients with esophageal cancer. Annual Congress of the European Association of Nuclear Medicine, Lyon, France, October 19-23, 2013.
6. Kuyumcu S, C Turkmen, A Mudun, S Unal, H Tokmak, Y Sanli, I Adalet, S Cantez Evaluation of iterative reconstruction versus conventional filtered backprojection in myocardial perfusion SPECT imaging in clinical practice. Annual Congress of the European Association of Nuclear Medicine, Helsinki, Finland, September 4-8; 2004.
7. H Tokmak, I Adalet, C Turkmen, H Boztepe, K Berberoglu, Y Sanli, M Tamam, Kuyumcu S, S Cantez Comparison of two different thyroid uptake method: Tc-99m throid uptake with a gama camera uptake and standart I-131 uptake. Annual Congress of the European Association of Nuclear Medicine, Helsinki, Finland, September 4-8; 2004.
8. D Has, Kuyumcu S, Y Sanli, E Yilmaz, C Turkmen, I Adalet The impact of SPECT/BT method to planar imaging in somatostatin receptor scintigraphy for the evaluation of neuroendocrine tumours.. Annual Congress of the European Association of Nuclear Medicine, Birmingham, UK, October 15-19; 2011
9. Y Sanli, Kuyumcu S, E Y lmaz, Z Ozkan, F Gungor, C Turkmen, S Unal, C Iyibozkurt The effect of additional delayed images for detection of peritoneal implants with (18)F-fluorodeoxyglucose (FDG) PET/CT. Annual Meeting of Society of Nuclear Medicine, 2012
10. EG Isik, E Yilmaz, Kuyumcu S, D Has, MF Gecer, S Unal, I Adalet Primary hyperparathyroidism presented as multipl brown tumours on bone scintigraphy due to an ectopic parathyroid lesion: A case report. Annual Congress of the European Association of Nuclear Medicine, Lyon, France, October 19-23, 2013
11. MF Gecer, E Y lmaz, EG Is k, Kuyumcu S, ZG Ozkan, B Ozcinar, Y Erbil, SN Unal The comparison of operation results and Tc99m-Sestamibi parathyroid scintigraphy SPECT/CT findings in patients who were operated due to hyperparathyroidism. Annual Congress of the European Association of Nuclear Medicine, Lyon, France, October 19-23, 2013
12. D Has, Kuyumcu S, F Gecer, Z Ozkan, E Yilmaz, Y Sanli, C Turkmen, F Buyukaya, I Adalet The evaluation of Grade 1 and Grade 2 gastroenteropancreatic neuroendocrine tumors with Ga68 Dotatate PET/CT.. Annual Congress of the European Association of Nuclear Medicine, Lyon, France, October 19-23, 2013.
13. G Alcin, ZG Ozkan, Y Sanli, Kuyumcu S, E Yilmaz, SN Unal 18F-FDG PET/CT for detecting Extensive Disease in Small-cell Lung Cancer. Annual Congress of the European Association of Nuclear Medicine, Gothenburg, Sweden, October 18-22, 2014
14. D Has Simsek, Kuyumcu S, Y Sanli, C Turkmen, NF Aykan, SN Unal, I Adalet The evaluation of Ga68-DOTA peptide PET/CT and F18-FDG PET/CT Finfings in Imaging of Primary Tumors and metastases of Gastroenteropancreatic Neuroendocrine Tumors. Annual Congress of the European Association of Nuclear Medicine, Gothenburg, Sweden, October 18-22, 2014
15. A Celik, M Oner, Kuyumcu S, Y Saygili, H Tokmak, C Türkmen, A Mudun, I Adalet, S Cantez Kemik Sintigrafisinde pinhole görüntülemenin planar görüntülere katkısı. 16. Ulusal Nükleer Tıp Kongresi, Samsun, 2003
16. Y Saygılı, Kuyumcu S, M Öner, A Celik, H Tokmak, C Türkmen, S Unal, I Adalet, S Cantez Diyabetik ayak lezyonlarının saptanmasında üç fazlı kemik sintigrafisi ve isaretli lökosit sintigrafisinde lateral görüntünün katkısı. 16. Ulusal Nükleer Tıp Kongresi, Samsun, 2003,
17. L Poyraz, C Türkmen, M Ince, Kuyumcu S, A Mudun, S Unal, I Adalet, S Cantez Iteratif konstrüksiyon parametrelerinin görüntü kalitesi üzerine etkisi. 17. Ulusal Nükleer Tıp Kongresi, Çesme, 2004,
18. H Tokmak, C Türkmen, I Adalet, H Boztepe, K Berberoglu, Y Sanli, M Tamam, Kuyumcu S, S Cantez Standart tiroid sintigrafisi sonrası 99mTc-perteknetat ile tiroid uptake’inin degerlendirilmesi ve standart 131I uptake’i ile karsılastırılması. 17. Ulusal Nükleer Tıp Kongresi, Çesme, 2004
19. Kuyumcu S, C Türkmen, A Mudun, S Unal, L Poyraz, H Tokmak, k Berberoglu, Y Sanli, m Tamam, I Adalet, S Cantez Miyokard perfüzyon SPECT görüntülerinin degerlendirilmesinde filtrelenmiş backprojection ve iteratif rekonstrüksiyon tekniklerinin karsılastırılması. 17. Ulusal Nükleer Tıp Kongresi, Çesme, 2004
20. ZG Ozkan, Y Sanli, Kuyumcu S, E Yilmaz, SN Unal Iyi diferansiye tiroid kanseri hastalarında rekürrens veya metastaz süphesinde 18F-FDG PET-BT’nin Yeri. 23. Ulusal Nükleer Tıp Kongresi, Izmir, 2011,
21. D Has, Y Sanli, Kuyumcu S, E Yilmaz, C Türkmen, I Adalet Nöroendokrin tümörlerin degerlendirilmesinde kullanılan IN-111 Oktreotid Sintigrafisinde SPECT/BT yönteminin planar görüntülemeye katkısı. 23. Ulusal Nükleer Tıp Kongresi, Izmir, 2011,
22. Kuyumcu S, Y Sanli, D Has, C Türkmen, S Keskin, F Tas, A Mudun Koroidal melanomda evreleme ve yeniden evrelemede PET-BT’nin rolü. 23. Ulusal Nükleer Tıp Kongresi, Izmir, 2011,
23. N Kadioglu, Y Sanli, Kuyumcu S, C Türkmen, I Adalet PET/BT görüntülemede kitle görünümü veren ektopik/atnalı böbrek: Olgu sunumu. 4. PET-BT Sempozyumu 18-20 Kasım 2011, Konya,
24. Y Sanli, Kuyumcu S, ZG Ozkan, C Türkmen, S Unal Rekürrens süpheli serviks kanseri olgusunda over transpozisyonu kaynaklı yalancı pozitif FDG tutulumu. 4. PET-BT Sempozyumu 18-20 Kasım 2011, Konya
25. Kuyumcu S, Y Sanli, D Has, C Türkmen, I Adalet 18F-FDG PET-BT görüntülemede retroperitoneal fibrozis: Olgu Sunumu. 4. PET-BT Sempozyumu 18-20 Kasım 2011, Konya,
26. E Yilmaz, N Kadioglu, Kuyumcu S, Y Sanli, ZG Ozkan, M Basaran, SN Unal Non Hodgkin Lenfoma tanılı hastada F-18 FDG PET/BT’ de bilateral böbrek ve üreter tutulumu. 4. PET-BT Sempozyumu 18-20 Kasım 2011, Konya,
27. D Has, Kuyumcu S, Y Sanli, ZG Özkan, B Özkan, C Türkmen, D Yilmazbayhan, A Mudun Malign Mezotelyoma Ön Tanısıyla Metabolik Karakterizasyon Amaçlı PET-BT Yapılan Olgularda FDG Tutulumunun Histopatolojik Bulgular ile Iliskisi. 24. Ulusal Nükleer Tıp Kongresi, Antalya, 4-8 Nisan 2012,
28. B Vatankulu, Y Sanli, Kuyumcu S, F Güngör, C Iyibozkurt, A Mudun, SN Ünal Plasental site trofoblastik tümör saptanan olguda PET/BT ile görüntüleme.. 24. Ulusal Nükleer Tıp Kongresi, Antalya, 4-8 Nisan 2012.
29. Y Sanli, Kuyumcu S, ZG Özkan, L Özer, E Balik, C Türkmen, D Has, G Isik, O Asoglu, Y Kapran, I Adalet FDG PET/BT’nin Kolorektal Kanser Rekürrensinin Belirlenmesinde Serum CEA Düzeylerinden Bagımsız Etkinligi. 24. Ulusal Nükleer Tıp Kongresi, Antalya, 4-8 Nisan 2012,
30. MF Gecer, G Alçın, ZG Özkan, Kuyumcu S, Y Sanli, E Yavuz, G Acunas, A Mudun Meme Lenfosintigrafide Intramammarial Lenf Nodu Olarak Degerlendirilen Fibroadenom Olgusu. 24. Ulusal Nükleer Tıp Kongresi, Antalya, 4-8 Nisan 2012,
31. EG Isik, Y Sanli, Kuyumcu S, E Yılmaz, ZG Ozkan, F Bezgal, Ö Kiliçoglu, F Dikici, B Zülfikar, C Türkmen Kronik Hemofilik Sinovit Tedavisinde Re-186 Kolloid ile Yapılan Radyosinovektomi Sonrası Eklem Içi Radyofarmasötik Dagılımının Tedavi Yanıtı ile Iliskisinin Karsılastırılması. 24. Ulusal Nükleer Tıp Kongresi, Antalya, 4-8 Nisan 2012, (Kontrol No: 1204849)
32. B Vatankulu, Y Sanli, Kuyumcu S, C Türkmen, O Asoglu, I Adalet Özofagus kanserlerinde FDG PET/BT’nin primer tümör ve uzak metastazları saptamadaki degeri. 24. Ulusal Nükleer Tıp Kongresi, Antalya, 4-8 Nisan 2012,
33. D Has, Kuyumcu S, MF Gecer, ZG Özkan, E yılmaz, Y Sanli, C Türkmen, I Adalet Grade 1 ve grade 2 gastroenteropankreatik nöroendokrin tümörlerin Ga-68 DOTATATE PET/BT ile degerlendirilmesi. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013
34. 20-MF Gecer, D Has, Kuyumcu S, E Yilmaz, ZG Özkan, Y Sanli, I Adalet Tc99m-sestaMIBI paratiroid sintigrafisinde multiglandüler paratiroid patolojisi düsünülen olgularda planar görüntülemeye SPECT ve SPECT/BT’nin katkısı. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013,
35. G Alçın, ZG Özkan, Kuyumcu S, MF Gecer, E Yılmaz, Y Sanli, C Türkmen, I Özden, I Adalet Major cerrahi öncesi degerlendirme amaçlı yapılan miyokard perfüzyon sintigrafisinin klinige etkisi. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013
36. ZG Özkan, A Uçar, Kuyumcu S, F Akyüz, A Poyanlı, S Keskin, KR Serin, E Yilmaz, Ç Karaca, C Türkmen Hepatosellüler karsinom hastalarında Yttrium-90 mikroküre ile yapılan selektif internal radyonüklid tedavi. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013,
37. G Alçın, Kuyumcu S, E Yılmaz, Y Sanli, ZG Özkan, D Has, A Mudun, SN Unal 68Ga-DOTATATE PET/CT yapılan hastalarda nöroendokrin tümör dısı tutulumlar. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013
38. ZG Özkan, Kuyumcu S, D Balköse, B Özkan, N Aksakal, E Yılmaz, Y Sanli, C Türkmen, F Aral, I Adalet Ektopik ACTH sendroumu’nda IN-111 Oktreotid sintigrafisi ve Ga-68 DOTATATE PET-BT’nin katkısı. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013,
39. EG Isik, Kuyumcu S, MF Gecer, E Yilmaz, ZG Özkan, Y Sanli, F Aral, S Çiftçi, I Adalet MEN 2A hastalarında I123 MIBG sintigrafisi ile klinik takip ve patoloji sonuçlarının karsılastırılması. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013
40. D Has, Kuyumcu S, E Yilmaz, ZG Özkan, Y Sanli, C Türkmen, I Adalet Papiller tiroid kanserinde (PTK) tüm vücut I-131 sintigrafisinde planar görüntülemede izlenen süpheli tutulumların degerlendirilmesinde SPECT-BT yönteminin katkısı (. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6- 10 Nisan, 2013,
41. MF Gecer, E Yılmaz, EG Isik, Kuyumcu S, ZG Özkan, B Özçınar, Y Erbil, SN Ünal Tc99m-SestaMIBI SPECT/BT ile paratiroid sintigrafisi sonrası hiperparatiroidi nedeniyle opere olmus hastalarda görüntüleme bulgularıyla operasyon sonuçlarının karsılastırılması.. 25. Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013,
42. EG Isik, E Yilmaz, Kuyumcu S, D Has, SN ünal, I Adalet Primer hiperparatiroidi ve kemik sintigrafisinde multiple brown tümöre yol açan ektopik paratiroid lezyonu: Olgu sunumu. 25.Ulusal Nükleer Tıp Kongresi, Antalya, 6-10 Nisan, 2013,
43. MF Gecer, E Yılmaz, EG Isik, Kuyumcu S, ZG Özkan, SN Ünal Ekstranodal ve splenik marjinal zon lenfoma tanılı hastalarda F18-FDG PET/BT görüntüleme. 26.Ulusal Nükleer Tıp Kongresi, 16-20 Nisan,Antalya, 2013,
44. G Alçın, Y Sanli, S Poyrazoglu, Kuyumcu S, ZG Özkan, E Yılmaz, N Gül, SN Unal Pediatrik yas grubunda diferansiye tiroid kanseri olgularının RAI tedavi sonuçlarının retrospektif degerlendirilmesi. 26.Ulusal Nükleer Tıp Kongresi, 16-20 Nisan,Antalya, 2013
45. EG Isik, E Yilmaz, D Has Simsek, Kuyumcu S, Y Sanli, C Türkmen, SN Unal Mantle hücreli lenfoma olgusunda periferik sinir ututlumunun F18 FDG PET-BT ile gösterilemsi: Olgu sunumu. 26.Ulusal Nükleer Tıp Kongresi, 16-20 Nisan,Antalya, 2013,
46. G Alçın, ZG Özkan, Y Sanli, Kuyumcu S, E Yılmaz, SN Unal Küçük hücreli akciger kanseri evrelemesinde F18 FDG PET-BT. 26.Ulusal Nükleer Tıp Kongresi, 16-20 Nisan,Antalya, 2013
47. Alçın G, Şanlı Y, Poyrazoğlu Ş, Kuyumcu S, Özkan ZG, Yılmaz E, Gül N, Ünal SN. Pediatrik yaş grubunda diferansiye tiroid kanseri olgularının RAİ tedavi sonuçlarının retrospektif değerlendirilmesi (26. Ulusal Nükleer Tıp Kongresi, 2014)
48. Has Şimşek D, Kuyumcu S, Türkmen C, Özkan ZG, Yılmaz E, Şanlı Y, Aykan NF, Adalet I. Gastroenteropankreatik nöroendokrin tümörlerin 68Ga-DOTApeptid ve 18F-FDG PET/BT ile değerlendirilmesi (26. Ulusal Nükleer Tıp Kongresi, 2014)
49. Alcin G, Ozkan ZG, Sanli Y, Kuyumcu S, Yilmaz E, Unal SN. 18F-FDG PET/CT for detecting Extensive Disease in Small-cell Lung Cancer (EANM 2014)
50. Geçer MF, Mudun A, Şanlı Y, Kuyumcu S, Yılmaz E, Özkan ZG, Işık EG, Kaşali K, Yavuz E, Karanlık H, Saip P, Türkmen C. Neoadjuvan kemoterapi uygulanan meme kanserli hastalarda PET/BT ile tedavi yanıtının değerlendirilmesi (27. Ulusal Nükleer Tıp Kongresi, 2015)
51. Özkan ZG, Mudun A, Kuyumcu S, Tüfekçioğlu Z, Şanlı Y, Türkmen C. Alzheimer tanısında vizüel F- 18 FDG PET-BT değerlendirilmesi sırasında karşılaşılabilecek prezentasyon şekilleri (27. Ulusal Nükleer Tıp Kongresi, 2015)
52. COVID-19 Sonrası Antikoagülan Kullanan Hastada Bilateral Embolinin Akciğer Perfüzyon Sintigrafisi ile Gösterilmesi. Dilara Denizmen, Emine Göknur Işık, Mustafa Erelel, Serkan Kuyumcu, Seher Nilgün Ünal. 33. Ulusal Nükleer Tıp Kongresi, 2021
53. Prostat Kanseri Tanılı Olgularda İnsidental Olarak Saptanan Akciğer Lezyonlarında Ga-68 PSMA PET/BT’nin Rolü Murat Yılmaz Kıran, Duygu Has Şimşek, Emine Göknur Işık, Serkan Kuyumcu, Zeynep Gözde Özkan, Yasemin Şanlı., 33. Ulusal Nükleer Tıp Kongresi, 2021
54. Metastatik Kastrasyona Dirençli Prostat Kanserinde Ac-225 PSMA Tedavisi: İlk Sonuçlarımız Yasemin Şanlı, Duygu Has Şimşek, Emine Göknur Işık, Caner Civan, Mert Başaran, Zeynep Gözde Özkan, Öner Şanlı, Fikret Büyükkaya, Serkan Kuyumcu Ulusal Nükleer Tıp Kongresi, 2021
55. Lu-177 DOTATATE Tedavisi Alan Tiroid Kanseri Hastalarında Ga-68 DOTATATE PET/BT ve Tümör Belirteçlerinin Rolü Caner Civan, Emine Göknur Işık, Duygu Has Şimşek, Serkan Kuyumcu, Seyfullah Karadoğan, Nail Paksoy, Yasemin Şanlı. 33. Ulusal Nükleer Tıp Kongresi, 2021
56. Tc-99m DMSA Sintigrafisinde Separe Böbrek Fonksiyonu Hesaplamada Planar (2D) ve SPECT (3D) Yöntemlerinin Karşılaştırılması Caner Civan, Duygu Has Şimşek, Murat Yılmaz Kıran, Emine Göknur Işık, Zeynep Gözde Özkan, Serkan Kuyumcu, Yasemin Şanlı. 33. Ulusal Nükleer Tıp Kongresi, 2021
57. Seyfullah Karadoğan, Yasemin Şanlı, Abdil Cem İbiş, Şükrü Mehmet Ertürk, Serkan Kuyumcu. Primer Karaciğer Malignitelerinde F-18 FDG ve Ga-68 FAPİ PET/BT Karşılaştırılması ve Tümör Belirteçleriyle Korelasyonu, 34.Ulusal Nükleer Tıp Kongresi
58. Edanur Topal, Yasemin Şanlı, Selçuk Erdem, Duygu Has Şimşek, Serkan Kuyumcu, Faruk Özcan, Öner Şanlı. Lokal/Lokal İleri Prostat Kanserinde Ga-68 PSMA PET/BT Görüntülemenin RP Öncesi Klinik Lenf Nodu Evrelemede Etkinliği, 34.Ulusal Nükleer Tıp Kongresi
59. Dilara Denizmen, Duygu Has Şimşek, Emine Göknur Işık, Zeynep Gözde Özkan, Yasemin Şanlı, Serkan Kuyumcu. MPS’de Koroner Kan Akımı Rezervinin İskemik Hastalığın Tespitindeki Rolü ve Klinik Risk Grubu ile İlişkisi: İlk Sonuçlar , 34.Ulusal Nükleer Tıp Kongresi
60. Bilal Kovan, Emine Göknur Işık, Fikret Büyükkaya, Zeynep Gözde Özkan, Bayram Demir, Arzu Poyanlı, Serkan Kuyumcu, Cüneyt Türkmen. Akciğer Şant Oranına Hareket ve Spillover Efektin Etkisi, 34.Ulusal Nükleer Tıp Kongresi
61. Bilal Kovan, Emine Göknur Işık, Zeynep Gözde Özkan, Bayram Demir, Yasemin Şanlı, Serkan Kuyumcu, Cüneyt Türkmen. İnternal Radyonüklid Tedavisinde Organ Doz Hesaplama Parametrelerinin Optimizasyonu, 34.Ulusal Nükleer Tıp Kongresi
62. Caner Civan, Zeynep Gözde Özkan, Berker Özkan, Emine Göknur Işık, Duygu Has Şimşek, Adnan Aydıner, Murat Kara, Yasemin Şanlı, Serkan Kuyumcu, Alper Toker. Timik Epitelyal Tümörlerde Ga-68 DOTATATE PET/BT Görüntüleme, 34.Ulusal Nükleer Tıp Kongresi
63. Dilara Denizmen, Duygu Has Şimşek, Emine Göknur Işık, Ayşe Mudun, Serkan Kuyumcu İnsidental Kardiyak Ga-18 FAPİ-04 Tutulumunun Kardiyovasküler Hastalıklar ile İlişkisi: Üç Olgu Sunumu, 34.Ulusal Nükleer Tıp Kongresi
64. Karadogan , Y. Sanli , S. M. Erturk , A. C. Ibis , S. Kuyumcu; [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT in Patients With Primary Liver Malignancies, 34.Ulusal Nükleer Tıp Kongresi
65. Isik, C. Civan, D. Has Simsek, Z. G. Özkan, N. Gül, S. M. Ertürk, Y. Sanli, S. Kuyumcu. Head to Head Comparison of [68Ga]Ga-FAPI-04 and [ 68Ga]Ga-DOTATATE PET/CT in Patients With Recurrence Medullary Thyroid Carcinoma, 34.Ulusal Nükleer Tıp Kongresi
66. Civan , Z. Ozkan , B. Ozkan , E. Isik , E. Erdogdu , D. Has Simsek , S. Duman , Y. Sanli , M. Kara , S. Kuyumcu , A. Toker; The role of 18F-FDG PET/CT on Characterization of Thymic Epithelial Tumors at Initial Stage, 34.Ulusal Nükleer Tıp Kongresi
67. Denizmen, D. Has Şimşek, E. G. Işık, A. Mudun, S. Kuyumcu; Incidental Cardiac 68Ga-FAPI-04 Uptake Related to Cardiovascular Diseases: Case Reports, 34.Ulusal Nükleer Tıp Kongresi

Bilimsel toplantılarda görevler

1. Konuşmacı: Dr Ali Uras anısına, “Kaybolan-Küçülen-Kimlik Değiştiren Karaciğer-Safra Yolları Kitleleri Çalıştayı” 6 Nisan 2013, İstanbul Tıp Fakültesi, İstanbul
2. Konuşmacı: “Antenatal Hidronefroz- Sintigrafik yaklaşım.”Büyük Üroloji Buluşması 31 Ekim- 3 Kasım 2013, Antalya
3. Konuşmacı: “Hastalarımızı radyasyondan nasıl koruruz?” Büyük Üroloji Buluşması 31 Ekim- 3 Kasım 2013, Antalya
4. Konuşmacı: “Kemik metastazlarında NaF- PET/BT.“ Ulusal Nükleer Tıp Kongresi, Antalya, 16-20 Nisan 2014
5. Konuşmacı: “GEP-NET’lerde Peptid Reseptör Radyonüklid Tedavi” Endokrinoloji ve Metabolizma Hastalıkları Mezuniyet Sonrası Eğitim Toplantısı, İstanbul, 15-16 Kasım 2014
6. Konuşmacı: “DOĞUM ÖNCESINDEN ERGENLIĞE HIDRONEFROZ KURSU: Olgular eşliğinde postnatal yaklaşım”13. Türk Çocuk Ürolojisi Kongresi, Antalya, 26-28 Kasım 2015
7. Konuşmacı: Peptide Receptor Radionuclide Therapy, 6th Annual Meeting of the Pakistan Society of Nuclear Medicine, 2018
8. Konuşmacı: FDG PET/CT Applications, Kosova Pristine
9. Oturum başkanlığı: Ulusal Nükleer Tıp Kongresi, Nisan 2018, Antalya
10. Oturum başkanlıkları: 31, 32, 34 Ulusal Nükleer Tıp Kongreleri
11. Konuşmacı: Ga-68 FAPI Görüntülemede Fizyolojik Dağılım, İnciler, Tuzaklar

Sempozyum / kongre katılımları

1. 18th Annual Congress of the European Society of Nuclear Medicine-EANM’05. 15-19 October 2005, Istanbul, Turkey
2. 24th Annual Congress of the European Society of Nuclear Medicine-EANM’11. 19-23 October 2011, Birmingham, UK
3. 26th Annual Congress of the European Society of Nuclear Medicine-EANM’13. 19-23 October 2013, Lyon, France
4. 27th Annual Congress of the European Society of Nuclear Medicine-EANM’14. 18-22 October, Gotheburg, Sweeden
5. Society of Nuclear Medicine and Molecular Imaging, 2015 Annual Meeting, June 6-10, 2015 in Baltimore, MD
6. 28th Annual Congress of the European Society of Nuclear Medicine-EANM’15, 10-14 October, Hamburg, Germany
7. 29th Annual Congress of the European Society of Nuclear Medicine-EANM’16, 15-19 October, Barcelona, Spain
8. 31^st Annual Congress of the European Society of Nuclear Medicine-EANM’18, 13-17 October, Dusseldorf, Germany
9. 32^nd Annual Congress of the European Society of Nuclear Medicine-EANM’19, October, Barcelona, Spain
10. 3^rd EANM FOCUS MEETING. Molecular Imaging And Theranostics In Neuroendocrine Tumours. ATHENS, GREECE, February, 2020
11. 35^th Annual Congress of the European Society of Nuclear Medicine-EANM’22, October, Barcelona, Spain
12. 6th International Congress of Nuclear Oncology and 17th National Congress of Turkish Society of Nuclear Medicine, May 1-5, 2004, Çeşme, İzmir.
13. Ulusal Nükleer Tıp Kongresi, 25-29 Nisan 2007, Adana
14. Ulusal Kanser Kongresi, 20-24 Nisan 2011, Antalya
15. Ulusal Nükleer Tıp Kongresi, 27 Nisan-1 Mayıs 2011, İzmir.
16. Nöroendokrin tümör tanı ve tedavisinde güncel gelişmeler sempozyumu, 16 Aralık 2011, Edirne.
17. 1st Balkan Congress of Nuclear Medicine. 4-8 April 2012, Antalya.
18. Ulusal Nükleer Tıp Kongresi, 6-10 Nisan 2013, Antalya
19. Büyük Üroloji Buluşması-I, 31 Ekim-03 Kasım 2013, Antalya
20. Ulusal Nükleer Tıp Kongresi, 16-20 Nisan 2014, Antalya
21. Ulusal Nükleer Tıp Kongresi, 1-5 Nisan 2015, Adana
22. Ulusal Nükleer Tıp Kongresi, 6-10 Nisan 2016, İzmir
23. Ulusal Nükleer Tıp Kongresi, Nisan 2018, Antalya
24. Ulusal Nükleer Tıp Kongresi / Balkan Nükleer Tıp Kongresi, Nisan 2019, Bodrum
25. Ulusal Nükleer Tıp Kongresi, Kasım 2020, Online
26. Ulusal Nükleer Tıp Kongresi, 2021, Online
27. Ulusal Nükleer Tıp Kongresi, Mart 2022, Antalya